Advertisement
Screener

ANAVEX LIFE SCIENCES CORP. (AVXL) Amortization of Debt Issuance Costs

1.4 / 5 stars · 14/51 Roast Me

ANAVEX LIFE SCIENCES CORP. Amortization of Debt Issuance Costs

ANAVEX LIFE SCIENCES CORP. (AVXL) reported Amortization of Debt Issuance Costs of $0 for the 9-month period ending 2015-06-30, per its 10-Q filed 2015-08-14.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AmortizationOfFinancingCosts · last filed 2016-12-14

  • ANAVEX LIFE SCIENCES CORP. amortization of debt issuance costs for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
  • ANAVEX LIFE SCIENCES CORP. amortization of debt issuance costs for the quarter ending 2014-09-30 was $1.11M.
  • ANAVEX LIFE SCIENCES CORP. amortization of debt issuance costs for the quarter ending 2014-06-30 was $8.85K.
  • ANAVEX LIFE SCIENCES CORP. amortization of debt issuance costs for the quarter ending 2014-03-31 was $1.20K.
  • ANAVEX LIFE SCIENCES CORP. amortization of debt issuance costs for fiscal 2014 was $1.12M, a 92378.35% increase from fiscal 2013.
  • ANAVEX LIFE SCIENCES CORP. amortization of debt issuance costs for fiscal 2013 was $1.22K, a 98.05% decline from fiscal 2012.
  • ANAVEX LIFE SCIENCES CORP. amortization of debt issuance costs for fiscal 2012 was $62.40K, a 40.11% increase from fiscal 2011.
  • ANAVEX LIFE SCIENCES CORP. amortization of debt issuance costs for fiscal 2011 was $44.54K, a 20.15% decline from fiscal 2010.
Period endAmortization of Debt Issuance Costs 3 monthAmortization of Debt Issuance Costs 6 monthAmortization of Debt Issuance Costs 9 monthAmortization of Debt Issuance Costs 12 monthAmortization of Debt Issuance Costs 89 monthAmortization of Debt Issuance Costs 92 monthAmortization of Debt Issuance Costs 95 monthAmortization of Debt Issuance Costs 98 monthAmortization of Debt Issuance Costs 101 monthAmortization of Debt Issuance Costs 104 monthAmortization of Debt Issuance Costs 107 monthAmortization of Debt Issuance Costs 110 monthAmortization of Debt Issuance Costs 113 monthAmortization of Debt Issuance Costs 116 monthAmortization of Debt Issuance Costs 119 monthAmortization of Debt Issuance Costs 122 month
2015-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-14
$0.00
10-Q · filed 2015-08-14
2015-03-31$0.00
10-Q · filed 2015-05-14
2014-09-30$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14
$1.12M
derived: sum of 2 quarters · filed 2016-12-14
$1.12M
derived: sum of 3 quarters · filed 2016-12-14
$1.12M
10-K · filed 2016-12-14
2014-06-30$8.85K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-14
$10.05K
derived: sum of 2 quarters · filed 2015-08-14
$10.05K
10-Q · filed 2015-08-14
$10.05K
derived: sum of 4 quarters · filed 2015-08-14
2014-03-31$1.20K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-14
$1.20K
10-Q · filed 2015-05-14
$1.20K
derived: sum of 3 quarters · filed 2015-05-14
$1.20K
derived: sum of 4 quarters · filed 2015-05-14
$165.13K
10-Q/A · filed 2014-05-30
2013-12-31$0.00
10-Q · filed 2014-02-14
$0.00
derived: sum of 2 quarters · filed 2014-12-29
$0.00
derived: sum of 3 quarters · filed 2014-12-29
$0.00
derived: sum of 4 quarters · filed 2014-12-29
$163.93K
10-Q · filed 2014-02-14
2013-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29
$0.00
derived: sum of 2 quarters · filed 2014-12-29
$0.00
derived: sum of 3 quarters · filed 2014-12-29
$1.22K
10-K · filed 2014-12-29
$163.93K
10-K · filed 2013-12-30
2013-06-30$0.00
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2014-08-13
$0.00
derived: sum of 2 quarters · filed 2014-08-13
$1.22K
10-Q · filed 2014-08-13
$2.90K
derived: sum of 4 quarters · filed 2014-08-13
$163.93K
10-Q · filed 2013-08-14
2013-03-31$0.00
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30
$1.22K
10-Q/A · filed 2014-05-30
$2.90K
derived: sum of 3 quarters · filed 2014-05-30
$18.14K
derived: sum of 4 quarters · filed 2014-05-30
$163.93K
10-Q · filed 2013-05-17
2012-12-31$1.22K
10-Q · filed 2014-02-14
$2.90K
derived: sum of 2 quarters · filed 2014-02-14
$18.14K
derived: sum of 3 quarters · filed 2014-02-14
$43.96K
derived: sum of 4 quarters · filed 2014-02-14
$163.93K
10-Q · filed 2013-02-14
2012-09-30$1.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30
$16.93K
derived: sum of 2 quarters · filed 2013-12-30
$42.74K
derived: sum of 3 quarters · filed 2013-12-30
$62.40K
10-K · filed 2013-12-30
$162.71K
10-K · filed 2012-12-31
2012-06-30$15.24K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-14
$41.06K
derived: sum of 2 quarters · filed 2013-08-14
$60.71K
10-Q · filed 2013-08-14
$105.25K
derived: sum of 4 quarters · filed 2013-08-14
$161.03K
10-Q · filed 2012-08-17
2012-03-31$25.82K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-17
$45.47K
10-Q · filed 2013-05-17
$90.01K
derived: sum of 3 quarters · filed 2013-05-17
$90.01K
derived: sum of 4 quarters · filed 2013-05-17
$145.78K
10-Q · filed 2012-05-15
2011-12-31$19.65K
10-Q · filed 2013-02-14
$64.19K
derived: sum of 2 quarters · filed 2013-02-14
$64.19K
derived: sum of 3 quarters · filed 2013-02-14
$64.19K
derived: sum of 4 quarters · filed 2013-02-14
$119.97K
10-Q · filed 2012-02-14
2011-09-30$44.54K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31
$44.54K
derived: sum of 2 quarters · filed 2012-12-31
$44.54K
derived: sum of 3 quarters · filed 2012-12-31
$44.54K
10-K · filed 2012-12-31
$100.31K
10-K · filed 2011-12-22
2011-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-17
$0.00
derived: sum of 2 quarters · filed 2012-08-17
$0.00
10-Q · filed 2012-08-17
$30.32K
derived: sum of 4 quarters · filed 2012-08-17
$55.78K
10-Q · filed 2011-08-12
2011-03-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15
$0.00
10-Q · filed 2012-05-15
$30.32K
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$0.00
10-Q · filed 2012-02-14
$30.32K
derived: sum of 2 quarters · filed 2012-02-14
2010-09-30$30.32K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22
$55.78K
10-K · filed 2011-12-22
2010-06-30$25.46K
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95